Ipamorelin 5 mg/Tesamorelin 5 mg

Dragon Pharma Ipamorelin/Tesamorelin

Ipamorelin/Tesamorelin 5 mg blend represents the pinnacle of peptide synergy for body recomposition, offering a scientifically optimized 1:1 ratio that delivers superior results compared to either peptide used in isolation. This third-party verified product contains 5.47 mg of Ipamorelin and 5.33 mg of Tesamorelin per vial—totaling 10.8 mg of active peptides with a remarkable 8% overfill that exemplifies Dragon Pharma's commitment to quality and customer value.

The Ipamorelin/Tesamorelin combination creates a powerful dual-mechanism approach to growth hormone optimization. Ipamorelin, a selective growth hormone secretagogue (GHRP), stimulates pulsatile GH release with minimal impact on cortisol or prolactin. Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, provides sustained GH elevation with particular affinity for reducing visceral abdominal fat—the most dangerous and stubborn fat type. Together, they create a comprehensive 24-hour anabolic environment that promotes lean tissue preservation while aggressively targeting adipose tissue, especially in the abdominal region.

Each vial is manufactured in Dragon Pharma's EU-certified facilities under pharmaceutical-grade conditions. The precisely blended lyophilized powder ensures consistent 1:1 dosing with every injection, eliminating the need to reconstitute and mix separate vials. For bodybuilders and fitness enthusiasts, this blend offers unprecedented convenience and efficacy: morning administration provides all-day metabolic enhancement and fat mobilization, while evening dosing leverages natural circadian GH rhythms for overnight recovery and muscle repair.

The scientific rationale behind this combination is profound: Tesamorelin's modification (with 40 out of 44 amino acids identical to natural GHRH) makes it resistant to degradation by dipeptidyl peptidase-IV, giving it an extended half-life and specific action on abdominal adipocytes. When combined with Ipamorelin's pulsatile stimulation, the result is both amplitude and duration enhancement of natural GH secretion without the negative feedback or receptor desensitization associated with exogenous HGH. When stacked with Dragon Pharma's Clenbuterol for thermogenic synergy or Masteron 100 for androgen-driven hardness, users achieve competition-ready conditioning that preserves muscle fullness and vascularity.

Key Benefits:

• Targeted Abdominal Fat Reduction: Tesamorelin specifically mobilizes visceral adipose tissue while Ipamorelin provides systemic lipolysis for comprehensive fat loss without muscle catabolism.
• Muscle Preservation During Cutting: Creates an anti-catabolic environment that protects lean tissue during calorie deficit, maintaining strength and performance while dieting.
• Enhanced Insulin Sensitivity: Improves glucose metabolism and nutrient partitioning, directing calories toward muscle instead of fat storage even during carbohydrate refeeds.
• Improved Lipid Profiles: Reduces triglycerides and LDL cholesterol while increasing HDL—crucial for cardiovascular health during intense cutting phases.
• 24-Hour Anabolic Coverage: Combines Ipamorelin's pulsatile action with Tesamorelin's sustained release for continuous growth hormone benefits throughout day and night.

Each 2 mL vial contains 5 mg Ipamorelin and 5 mg Tesamorelin (actual 5.47 mg/5.33 mg per independent lab analysis), precision-blended under strict quality control standards in Dragon Pharma's certified European facilities.

Product Specifications

Usage Guidelines

The Ipamorelin/Tesamorelin blend is administered via subcutaneous injection. Reconstitute the 10 mg blend with 1-2 mL of bacteriostatic water. For optimal results, split the daily dose into two administrations: morning (upon waking) and evening (before bedtime). This schedule leverages Tesamorelin's long half-life for all-day metabolic enhancement while utilizing Ipamorelin's pulsatile action during natural GH peaks. Use insulin syringes (0.3cc or 0.5cc) for precise dosing. Inject into abdominal subcutaneous fat, rotating sites to prevent lipohypertrophy.

• Beginner Cycle (8 weeks): 100 mcg of each peptide once daily (pre-bed). Ideal for assessing tolerance and initial body recomposition. Can be stacked with Cardarine (GW501516) for enhanced fat oxidation during cardio sessions.
• Intermediate Cycle (10 weeks): 100 mcg of each peptide twice daily (morning & pre-bed). For significant fat loss with muscle preservation. Pairs effectively with Anavar 10 for a clean, dry cutting phase with enhanced vascularity.
• Advanced Cycle (12 weeks): 150 mcg of each peptide twice daily. Maximum dosing for competition preparation or stubborn fat loss. Often stacked with Trenbolone 50 for extreme conditioning or Winstrol 10 for competition-level hardness and density.

Post Cycle Therapy (PCT):

Neither Ipamorelin nor Tesamorelin suppress the HPTA axis, so traditional testosterone recovery protocols aren't necessary. However, natural GH production may experience temporary downregulation after extended cycles. A 4-week break between 12-week cycles is recommended. During this time, consider natural GH secretagogues or lighter peptides like Semax 5mg for cognitive and recovery benefits. If used alongside suppressive compounds, follow appropriate PCT with Enclomiphene or Toremifene.

Blood Glucose Management:

This blend can transiently affect blood glucose levels. Monitor for signs of hypoglycemia, especially when combining with other insulin-sensitizing compounds. Consume 15-20g of complex carbohydrates if experiencing lightheadedness post-injection. For users with metabolic conditions or those stacking with Metformin, more careful glucose monitoring is advised. Avoid administering on a completely empty stomach.

Third-Party Lab Tested

2025-11-10

View Result

5.47 mg/5.33 mg

Storage Instructions

• Unreconstituted: Store lyophilized Ipamorelin/Tesamorelin blend vials at 2-8°C (36-46°F) in their original packaging. Refrigeration is mandatory for long-term stability (up to 24 months). Avoid freezing the powder form as condensation during thawing can degrade peptide integrity.
• Reconstituted: After mixing with bacteriostatic water, store immediately in refrigerator at 2-8°C (36-46°F). Use within 21 days for optimal potency. The blend remains stable at room temperature for up to 24 hours if needed for travel, but consistent refrigeration is strongly recommended.
• Handling Protocol: Protect from light exposure at all stages. Allow refrigerated vials to reach room temperature before reconstitution to prevent condensation. Use alcohol swabs on vial tops before each puncture. Gently swirl (never shake) to dissolve powder. Always use fresh insulin syringes for each injection to maintain sterility and dosing accuracy.